Paul B. Manning

Insider Reports History

Location
200 Garrett Street Suite S, Charlottesville, VA
Signature
/s/ Mark Ballantyne, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul B. Manning:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Liquidia Corp Director Common Stock 3.13M $87.7M $28.00 Aug 28, 2025 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 3.96M $16.8M $4.24 Nov 25, 2025 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 3.35M $14.2M $4.24 Nov 25, 2025 Indirect
Liquidia Corp Director Common Stock 431K $12.6M $29.14 Sep 2, 2025 Indirect
Candel Therapeutics, Inc. Director Common Stock 2.21M $10.3M $4.67 Jun 25, 2025 By Paul B. Manning Revocable Trust
Candel Therapeutics, Inc. Director Common Stock 1.68M $8.09M $4.81 Jun 25, 2025 Direct
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 2.84M $7.81M $2.75 May 30, 2025 Indirect
Candel Therapeutics, Inc. Director Common Stock 1.3M $6.27M $4.81 Jun 25, 2025 By BKB Growth Investments, LLC
Acumen Pharmaceuticals, Inc. 10%+ Owner Common Stock 658K $2.28M $3.47 Jul 6, 2021 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Common Stock 332K $1.17M $3.53 Nov 25, 2025 By trust
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series A Warrants (right to buy) 9.21M Nov 22, 2024 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series B Warrants (right to buy) 9.21M Nov 22, 2024 Direct
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series A Warrants (right to buy) 2.25M Nov 22, 2024 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series B Warrants (right to buy) 2.25M Nov 22, 2024 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series C Warrant (right to buy) 688K Nov 25, 2025 Indirect
Verrica Pharmaceuticals Inc. Director, 10%+ Owner Series C Warrant (right to buy) 344K Nov 25, 2025 Direct
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 14.2K Jun 17, 2025 Direct
Acumen Pharmaceuticals, Inc. 10%+ Owner Series A-1 Preferred Stock 0 Jul 6, 2021 Indirect
Acumen Pharmaceuticals, Inc. 10%+ Owner Series B Preferred Stock 0 Jul 6, 2021 Indirect

Insider Reports Filed by Paul B. Manning

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Nov 25, 2025 4 $17.5M 4 Nov 25, 2025 Director, 10%+ Owner
LQDA Liquidia Corp Aug 28, 2025 4 -$19M 4 Sep 2, 2025 Director
CADL Candel Therapeutics, Inc. Jun 25, 2025 1 $5M 4 Jun 26, 2025 Director
LQDA Liquidia Corp Jun 17, 2025 1 $0 4 Jun 20, 2025 Director
CADL Candel Therapeutics, Inc. Jun 17, 2025 1 $0 4 Jun 18, 2025 Director
TSHA Taysha Gene Therapies, Inc. May 30, 2025 1 $2.06M 4 Jun 3, 2025 10%+ Owner
CADL Candel Therapeutics, Inc. Dec 16, 2024 2 $7.5M 4 Dec 18, 2024 Director
VRCA Verrica Pharmaceuticals Inc. Nov 22, 2024 7 $0 4 Nov 26, 2024 Director, 10%+ Owner
VRCA Verrica Pharmaceuticals Inc. Sep 19, 2024 4 $0 4 Sep 23, 2024 Director, 10%+ Owner
LQDA Liquidia Corp Sep 12, 2024 1 $3M 4 Sep 16, 2024 Director
TSHA Taysha Gene Therapies, Inc. Jun 27, 2024 1 $3M 4 Jul 1, 2024 10%+ Owner
CADL Candel Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 27, 2024 Director
LQDA Liquidia Corp Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
LQDA Liquidia Corp Dec 14, 2023 1 $2M 4 Dec 18, 2023 Director
TSHA Taysha Gene Therapies, Inc. Nov 17, 2023 1 $163K 4 Nov 20, 2023 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Aug 16, 2023 1 $14.8M 4 Aug 16, 2023 10%+ Owner
VRCA Verrica Pharmaceuticals Inc. Jul 24, 2023 1 $1M 4 Jul 24, 2023 Director, 10%+ Owner
CADL Candel Therapeutics, Inc. Jun 28, 2023 1 $0 4 Jun 29, 2023 Director
LQDA Liquidia Corp Jun 19, 2023 1 $0 4 Jun 21, 2023 Director
TSHA Taysha Gene Therapies, Inc. Oct 31, 2022 1 $3M 4 Nov 2, 2022 Director, 10%+ Owner
CADL Candel Therapeutics, Inc. Oct 13, 2022 1 $0 4 Oct 17, 2022 Director
VRCA Verrica Pharmaceuticals Inc. Jul 5, 2022 1 $10M 4 Jul 5, 2022 Director, 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Jun 17, 2022 1 $0 4 Jun 22, 2022 Director, 10%+ Owner
LQDA Liquidia Corp Jun 17, 2022 1 $0 4 Jun 22, 2022 Director
LQDA Liquidia Corp Apr 18, 2022 1 $2M 4 Apr 19, 2022 Director
LQDA Liquidia Corp Mar 31, 2022 1 $0 4 Apr 20, 2022 Director
TSHA Taysha Gene Therapies, Inc. Feb 2, 2022 5 $1.57M 4 Feb 4, 2022 Director, 10%+ Owner
LQDA Liquidia Corp Dec 31, 2021 0 $0 5/A May 4, 2022 Director, 10%+ Owner
VRCA Verrica Pharmaceuticals Inc. Dec 31, 2021 2 $0 5 Feb 14, 2022 Director, 10%+ Owner
CADL Candel Therapeutics, Inc. Dec 31, 2021 1 $0 5 Feb 14, 2022 Director, 10%+ Owner
VRCA Verrica Pharmaceuticals Inc. Dec 2, 2021 2 $468K 4 Dec 6, 2021 Director, 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Nov 24, 2021 1 $29K 4 Nov 29, 2021 Director, 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Nov 23, 2021 1 $251K 4 Nov 24, 2021 Director, 10%+ Owner
LQDA Liquidia Corp Aug 20, 2021 1 $0 4 Sep 1, 2021 Director
CADL Candel Therapeutics, Inc. Jul 29, 2021 5 $13M 4/A Aug 4, 2021 Director, 10%+ Owner
CADL Candel Therapeutics, Inc. Jul 27, 2021 2 $411K 4 Jul 29, 2021 Director
CADL Candel Therapeutics, Inc. Jul 26, 2021 0 $0 3 Jul 26, 2021 Director
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 6 $5M 4 Jul 8, 2021 10%+ Owner
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director, 10%+ Owner
TSHA Taysha Gene Therapies, Inc. May 14, 2021 1 $252K 4 May 17, 2021 Director, 10%+ Owner